KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $10.0 million.

  • Merck's Exchange Rate Effect fell 9659.86% to $10.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $173.0 million, marking a year-over-year decrease of 3346.15%. This contributed to the annual value of -$293.0 million for FY2024, which is 137391.3% down from last year.
  • Latest data reveals that Merck reported Exchange Rate Effect of $10.0 million as of Q3 2025, which was down 9659.86% from $374.0 million recorded in Q2 2025.
  • Merck's 5-year Exchange Rate Effect high stood at $374.0 million for Q2 2025, and its period low was -$412.0 million during Q3 2022.
  • Over the past 5 years, Merck's median Exchange Rate Effect value was -$55.0 million (recorded in 2022), while the average stood at -$14.4 million.
  • The largest annual percentage gain for Merck's Exchange Rate Effect in the last 5 years was 63823.53% (2022), contrasted with its biggest fall of 79565.22% (2022).
  • Over the past 5 years, Merck's Exchange Rate Effect (Quarter) stood at -$68.0 million in 2021, then surged by 638.24% to $366.0 million in 2022, then tumbled by 49.18% to $186.0 million in 2023, then tumbled by 297.31% to -$367.0 million in 2024, then surged by 102.72% to $10.0 million in 2025.
  • Its Exchange Rate Effect was $10.0 million in Q3 2025, compared to $374.0 million in Q2 2025 and $156.0 million in Q1 2025.